

Considerable attrition was seen across the chronic hepatitis B care cascade, with low rates of retention especially in patients not on antiviral therapy. Assessment for treatment eligibility and initiation of antiviral therapy were lower in primary versus hospital-based specialist care models. Chronic hepatitis B services need to adopt strategies to optimise linkage to care after diagnosis, initiation of antiviral therapy if eligible, adherence to antiviral therapy and retention in care, as promoted in 2024 WHO hepatitis B guidelines.
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet